|
Volumn 16, Issue 2, 2006, Pages 805-808
|
Does immediate hormone replacement therapy affect the oncologic outcome in endometrial cancer survivors?
|
Author keywords
Endometrial cancer; Hormone replacement therapy; Oncologic outcome
|
Indexed keywords
CONJUGATED ESTROGEN;
MEDROXYPROGESTERONE ACETATE;
ADULT;
AGE;
AGED;
ARTICLE;
CANCER INVASION;
CANCER MORTALITY;
CANCER RECURRENCE;
CANCER SIZE;
CANCER STAGING;
CANCER SURVIVOR;
CASE CONTROL STUDY;
CLINICAL ARTICLE;
CONTROLLED STUDY;
ENDOMETRIUM CANCER;
FEMALE;
FOLLOW UP;
HISTOPATHOLOGY;
HORMONE SUBSTITUTION;
HUMAN;
PARITY;
PRIORITY JOURNAL;
PROGNOSIS;
PROSPECTIVE STUDY;
STATISTICAL ANALYSIS;
SYSTEMIC DISEASE;
ADULT;
AGED;
ANTINEOPLASTIC AGENTS, HORMONAL;
CASE-CONTROL STUDIES;
DISEASE PROGRESSION;
ENDOMETRIAL NEOPLASMS;
ESTROGENS;
ESTROGENS, CONJUGATED (USP);
FEMALE;
HORMONE REPLACEMENT THERAPY;
HUMANS;
LYMPHATIC METASTASIS;
MEDROXYPROGESTERONE 17-ACETATE;
MIDDLE AGED;
NEOPLASM INVASIVENESS;
PROSPECTIVE STUDIES;
SURVIVORS;
TREATMENT OUTCOME;
|
EID: 33646061967
PISSN: 1048891X
EISSN: 15251438
Source Type: Journal
DOI: 10.1111/j.1525-1438.2006.00526.x Document Type: Article |
Times cited : (62)
|
References (10)
|